Free Trial
LON:TGP

Tekmar Group (TGP) Share Price, News & Analysis

GBX 6.15 -0.10 (-1.60%)
As of 05:48 AM Eastern

About Tekmar Group Stock (LON:TGP)

Key Stats

Today's Range
6
6.50
50-Day Range
4.60
6.50
52-Week Range
4
10.20
Volume
192,814 shs
Average Volume
250,337 shs
Market Capitalization
£8.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TGP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekmar Group and its competitors with MarketBeat's FREE daily newsletter.

TGP Stock News Headlines

Trump’s biggest move, misreported
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.
River Global Increases Stake in Tekmar Group
Tekmar Group Sees Adjustments in Major Shareholdings
See More Headlines

TGP Stock Analysis - Frequently Asked Questions

Tekmar Group's stock was trading at GBX 6 at the start of the year. Since then, TGP stock has increased by 2.5% and is now trading at GBX 6.15.

Tekmar Group plc (LON:TGP) issued its quarterly earnings data on Thursday, June, 26th. The company reported ($1.50) EPS for the quarter. Tekmar Group had a negative trailing twelve-month return on equity of 53.81% and a negative net margin of 23.74%.

Shares of TGP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tekmar Group investors own include Recursion Pharmaceuticals (RXRX), CRISPR Therapeutics (CRSP), Newmont (NEM), ADMA Biologics (ADMA), Butterfly Network (BFLY), DarioHealth (DRIO) and Fortress Biotech (FBIO).

Company Calendar

Last Earnings
6/26/2025
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Engineering & Construction
Sub-Industry
N/A
Current Symbol
LON:TGP
CIK
N/A
Fax
N/A
Employees
172
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (3.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£4.29 million
Net Margins
-23.74%
Pretax Margin
N/A
Return on Equity
-53.81%
Return on Assets
-9.26%

Debt

Debt-to-Equity Ratio
21.65
Current Ratio
1.59
Quick Ratio
1.70

Sales & Book Value

Annual Sales
£18.08 million
Price / Sales
0.45
Cash Flow
GBX 15.06 per share
Price / Cash Flow
0.41
Book Value
GBX 12.13 per share
Price / Book
0.51

Miscellaneous

Outstanding Shares
131,545,662
Free Float
N/A
Market Cap
£8.09 million
Optionable
Not Optionable
Beta
2.06
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:TGP) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners